NEW YORK (GenomeWeb) – Health information company Sema4 said today that it plans to leverage GNS Healthcare's machine learning and simulation platform in its drug discovery and development pipelines.

The companies plan to first focus on discovering the underlying drivers of cardiovascular disease and identifying existing drugs to treat it as well as opportunities for developing novel therapies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.